ASX - Delayed Quote AUD

Bio-Gene Technology Limited (BGT.AX)

0.0490

-0.0030

(-5.77%)

At close: 4:10:45 PM GMT+11

Bio-Gene Technology And 2 Other ASX Penny Stocks To Watch For Growth

The Australian market has been showing positive momentum, with the ASX200 up 0.49% as investor sentiment is buoyed by expectations of an RBA rate cut. In such a climate, identifying stocks that combine affordability with growth potential can be particularly appealing to investors looking for opportunities beyond traditional sectors. Although the term 'penny stock' may seem outdated, these smaller or newer companies often hold promise when backed by solid financials, offering a chance for...

Simply Wall St. yesterday

BGT.AX
-5.77%
GRX.AX

PEX.AX
Bio-Gene and Envu Collaborate to Evaluate Flavocide™ for Use in Public and Private Sector Mosquito Management

MELBOURNE, Australia & CARY, N.C., August 14, 2024--Bio-Gene Technology Limited (ASX:BGT or ‘Bio-Gene’), an Australian company developing the next generation of novel bio-insecticides, and Envu are evaluating Flavocide™ for use in professional pest management and public health products to control mosquitoes.

Business Wire 5 months ago

BGT.AX
-5.77%

Performance Overview

Return	BGT.AX	S&P/ASX 200 [XJO]
YTD	+13.95%	+4.57%
1-Year	-12.50%	+11.09%
3-Year	-78.70%	+22.39%